GENE ONLINE|News &
Opinion
Blog

Feature
Biogen Concludes $900 Million Settlement Before Posting Positive Data From Alzheimer’s Trial
2022-09-28
Pfizer Pledges 6 million COVID-19 Treatment Courses to Global Fund
2022-09-22
ESMO 2022: Promising Trials Highlights That Are Worth Following
2022-09-21
The COVID-19 Pandemic: Is Omicron the Last Variant?
2022-09-16
A Cure for HIV Could Be Here Sooner Than You Think – Future of Health
2022-09-16
Defeating Head and Neck Cancer, From Combination Therapy to Photoimmunotherapy
2022-09-15Partner
WHO Urges Action After Model Suggests Over 17 Million Europeans Experienced Long COVID
2022-09-14
Second Monkeypox Death as Antiviral Enters Phase 3 Clinical Trial
2022-09-12
Monkeypox Update: New FDA Testing Guidelines as the US Passes 20,000 Cases
2022-09-08
HHS Strikes Deal With AmerisourceBergen for Expanded Monkeypox Treatment Distribution
2022-09-07
Four Dead as Authorities Confirm Argentina Pneumonia Outbreak Caused by Legionella
2022-09-04
Monkeypox Cases Fall In The UK But A New Strain Of The Disease Emerges
2022-09-02
Just How Deadly is Monkeypox? Reported Death in Texas While Vaccine Production Ramps Up
2022-09-01
Scaling up Korea’s Biotech Presence in The Global Value Chain, an Interview with Seung Kyou Lee, Vice President of KoreaBIO
2022-08-31
U.S. Government to No Longer Provide Free COVID-19 Vaccines
2022-08-31
1 2 3 49
LATEST
AstraZeneca Welcomes Neurofibromatosis And Asthma Treatment Approvals in Japan
2022-09-28
Arsenal Biosciences Announced Another $70 million Collaboration, This Time With Genentech
2022-09-27
Sciwind Biosciences And SynerK Join Forces To Develop siRNA Therapeutics
2022-09-27
Acticor Enrolls First Patient in Phase 2/3 Stroke Treatment Study
2022-09-27
Daiichi Sankyo Wins Approval For Cancer Treatment in Japan
2022-09-26
Seagen Strikes Potential $650 million Deal with LAVA Therapeutics for Cancer Treatment
2022-09-26
Pfizer, Sangamo Re-Opens Enrolment For Hemophilia A Gene Therapy
2022-09-26
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!